formats

HSS Doctor Offers Latest Treatments…and Compassion to Patients with Autoimmune Disorders

Imagine waking up one morning and feeling achy all over. As days pass, the achiness doesn’t go away, and you begin to feel tired, too. Your doctor can’t tell you exactly what’s wrong. So you go to a specialist, but the cause of your symptoms remains a mystery. Dr. Michael Lockshin, director of The Barbara

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on HSS Doctor Offers Latest Treatments…and Compassion to Patients with Autoimmune Disorders  comments 
formats

*Sex and Autoimmune Disease

Follow the links below to the Hospital for Special Surgery web site and read Dr. Lockshin’s articles about Sex and Autoimmune Disease: Autoimmune Disease: Does Sex Matter? Current Theories Gender and Rheumatoid Arthritis Summary of a presentation at the Living with RA Workshop at HSS

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on *Sex and Autoimmune Disease  comments 
formats

Couple Honors Physician with Bequest

Grateful for the extraordinary care they have received at Hospital for Special Surgery, Maria and Morris Coppersmith have chosen to name the Hospital in their wills. "My wife and I want to leave our estate to organizations that have made an impact on our lives, such as HSS, especially because we don't have any children,"

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Couple Honors Physician with Bequest  comments 
formats

Antiphospholipid Syndrome: Essential Information and Support FAQs

Public and Patient Education Department Program, October 17 and 24, 2006 Michael D. Lockshin, MD How many days before a colonoscopy procedure should a person with APS cease taking their prescribed 81mg of aspirin or other similar medications? The amount of time before a procedure should be approximately 1 week for aspirin, clopidogrel (Plavix) or

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Antiphospholipid Syndrome: Essential Information and Support FAQs  comments 
formats

Unlocking the Mystery of Lupus: Lupus & the Heart FAQs

S.L.E. Lupus Foundation “Get into the Loop” NYC Hospital Tour, Public and Patient Education Department Program, November 3, 2005 Michael D. Lockshin, MD What is lupus? Systemic lupus erythematosus (SLE), commonly called lupus, is a chronic autoimmune disorder that can affect virtually any organ of the body. In lupus, the body’s immune system, which normally

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Unlocking the Mystery of Lupus: Lupus & the Heart FAQs  comments 
formats

An Overview of Lupus Research: Where We’ve Been and Where We’re Going

Summary of a presentation given at the SLE Workshop at Hospital for Special Surgery Michael D. Lockshin, MD • What is Clinical Research? • Conducting Clinical Research: Safety and Confidentiality • Treatment Trials • Trial Phases • Kinds of Drugs Observed in Clinical Trials • Aims of Lupus Research • Lupus Clinical Trial Consortium •

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on An Overview of Lupus Research: Where We’ve Been and Where We’re Going  comments 
formats

Hospital for Special Surgery’s Dr. Michael Lockshin Appointed Editor of Arthritis and Rheumatism

Michael D. Lockshin, MD of Hospital for Special Surgery (HSS) in New York City has been appointed editor of Arthritis and Rheumatism, the official publication of the American College of Rheumatology and a leading rheumatology journal. The American College of Rheumatology made the announcement of Dr. Lockshin's appointment following its recent annual meeting in San

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Hospital for Special Surgery’s Dr. Michael Lockshin Appointed Editor of Arthritis and Rheumatism  comments 
formats

Reflections on the Withdrawal of Vioxx from the Market

Three years ago, at a journal club presentation at our hospital and on the hospital web site, I expressed my opinion that the data then available suggesting an excess cardiovascular risk from use of Vioxx (rofecoxib) were inconclusive. I based this opinion on the following. The data compared a large dose of Vioxx (50 mg

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Reflections on the Withdrawal of Vioxx from the Market  comments 
formats

Antiphospholipid Antibody Syndrome – In-Depth Overview

Adapted from a talk at The SLE Workshop at Hospital for Special Surgery A syndrome is a collection of events that constitute a specific illness. Antiphospholipid Antibody Syndrome (APS) includes a series of symptoms as follows:  Repeated clotting in veins (for example – a pulmonary embolus) or arteries (examples include a stoke, a blood clot

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Antiphospholipid Antibody Syndrome – In-Depth Overview  comments 
formats

How long is it necessary to treat active SLE with immunosuppressive drugs? Can immunosuppressive therapy be discontinued? If so, when

Ask the Expert  If you look in current texts, or even on this web site, you do not easily find answers to these very basic questions. The reasons clear answers are hard to come by reflect the great diversity of clinical manifestations of lupus, its proclivity to flare and remit unpredictably, and the long follow-up

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on How long is it necessary to treat active SLE with immunosuppressive drugs? Can immunosuppressive therapy be discontinued? If so, when  comments